Themis Medicare Overview
- Year Founded
-
1969

- Status
-
Public
- Employees
-
1,541

- Stock Symbol
-
530199

- Share Price
-
$1.45
- (As of Thursday Closing)
Themis Medicare General Information
Description
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
Contact Information
Website
www.themismedicare.comCorporate Office
- 11/12, Udyog Nagar
- S. V. Road, Goregaon (W)
- Mumbai, Maharastra 400104
- India
Corporate Office
- 11/12, Udyog Nagar
- S. V. Road, Goregaon (W)
- Mumbai, Maharastra 400104
- India
Themis Medicare Stock Performance
As of 10-Jul-2025, Themis Medicare’s stock price is $1.45. Its current market cap is $133M with 92M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.45 | $1.46 | $1.33 - $3.71 | $133M | 92M | 16.2K | $0.04 |
Themis Medicare Financials Summary
As of 31-Mar-2025, Themis Medicare has a trailing 12-month revenue of $48M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 |
---|---|---|---|---|
EV | 164,750 | 164,750 | 249,759 | 137,310 |
Revenue | 47,959 | 47,959 | 46,114 | 42,897 |
EBITDA | 7,054 | 7,054 | 9,068 | 11,265 |
Net Income | 3,528 | 3,528 | 5,257 | 7,086 |
Total Assets | 68,744 | 68,744 | 67,921 | 62,600 |
Total Debt | 9,702 | 9,702 | 11,487 | 11,251 |
Themis Medicare Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Themis Medicare Patents
Themis Medicare Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4076442-A1 | Pharmaceutical composition of cyclooxygenase - 2 inhibitors | Inactive | 16-Dec-2019 | ||
EP-4076442-A4 | Pharmaceutical composition of cyclooxygenase - 2 inhibitors | Inactive | 16-Dec-2019 | ||
US-20230073803-A1 | Pharmaceutical composition of cyclooxygenase - 2 inhibitors | Pending | 16-Dec-2019 | ||
CA-3001526-A1 | Fulvestrant compositions | Inactive | 13-Oct-2015 | ||
EP-3362046-A1 | Fulvestrant compositions | Inactive | 13-Oct-2015 | A61K31/565 |
Themis Medicare Signals
Themis Medicare FAQs
-
When was Themis Medicare founded?
Themis Medicare was founded in 1969.
-
Where is Themis Medicare headquartered?
Themis Medicare is headquartered in Mumbai, India.
-
What is the size of Themis Medicare?
Themis Medicare has 1,541 total employees.
-
What industry is Themis Medicare in?
Themis Medicare’s primary industry is Pharmaceuticals.
-
Is Themis Medicare a private or public company?
Themis Medicare is a Public company.
-
What is Themis Medicare’s stock symbol?
The ticker symbol for Themis Medicare is 530199.
-
What is the current stock price of Themis Medicare?
As of 10-Jul-2025 the stock price of Themis Medicare is $1.45.
-
What is the current market cap of Themis Medicare?
The current market capitalization of Themis Medicare is $133M.
-
What is Themis Medicare’s current revenue?
The trailing twelve month revenue for Themis Medicare is $48M.
-
What is Themis Medicare’s annual earnings per share (EPS)?
Themis Medicare’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »